Aclaris Therapeutics, Inc. (ACRS): Gross Profit
$5.74M
Year ended 2025-12-31
$6.54M
Trailing 12 months to 2026-06-30
-39.4%
3-year compound annual growth
+33.6%
5-year compound annual growth
| Period ended | Gross Profit | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | $5.74M | -64.0% | 2026-02-26, From 2025-01-01 |
| 2024-12-31 | $15.93M | -42.8% | 2026-02-26, From 2024-01-01 |
| 2023-12-31 | $27.83M | +8.2% | 2025-02-27, From 2023-01-01 |
| 2022-12-31 | $25.73M | n/m | 2024-02-27, From 2022-01-01 |
| 2021-12-31 | $2.05M | +51.8% | 2024-02-27, From 2021-01-01 |
| 2020-12-31 | $1.35M | +684.3% | 2023-02-23, From 2020-01-01 |
| 2019-12-31 | $172.0K | -90.6% | 2022-02-24, From 2019-01-01 |
| 2018-12-31 | $1.82M | +282.8% | 2021-02-25, From 2018-01-01 |
| 2017-12-31 | $476.0K | n/a | 2020-02-25, From 2017-01-01 |
Gross Profit at similar companies
| Company | Year ended | Gross Profit | Change YoY |
|---|---|---|---|
| Aclaris Therapeutics, Inc. (ACRS) | 2025-12-31 | $5.74M | -64.0% |
| Whitehawk Therapeutics, Inc. (WHWK) | 2025-12-31 | $6.38M | -72.2% |
| International Stem Cell Corp (ISCO) | 2025-12-31 | $5.07M | -4.8% |
| Jaguar Health, Inc. (JAGX) | 2025-12-31 | $7.74M | -20.5% |
| Emmaus Life Sciences, Inc. (EMMA) | 2025-12-31 | $11.60M | -25.0% |
| Tonix Pharmaceuticals Holding Corp. (TNXP) | 2025-12-31 | $6.47M | +177.7% |
| CV Sciences, Inc. (CVSI) | 2025-12-31 | $6.75M | -5.8% |
| Pyxis Oncology, Inc. (PYXS) | 2025-12-31 | $11.47M | n/a |
| ProPhase Labs, Inc. (PRPH) | 2025-12-31 | $1.38M | n/m |
Compare ACRS, WHWK, ISCO, JAGX side by side · Screen every company in Pharmaceutical Preparations ↗